Novel antithrombotics based on modulation of the protein C pathway.
Grinnell
B W
BW
Division of Research Technologies and Proteins, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285-0444, USA.
Yan
S B
SB
D000818:Animals; D000991:Antithrombins / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D011486:Protein C / Q000378:metabolism / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D018180:Thrombomodulin / Q000378:metabolism
D000991:Antithrombins; D011486:Protein C; D011994:Recombinant Proteins; D018180:Thrombomodulin